Lara PN - Search Results

1

Phase II study of Aflibercept (VEGF-Trap) in patients with recurrent or metastatic urothelial cancer, a California Cancer Consortium Trial.

Twardowski P, Stadler WM, Frankel P, Lara PN, Ruel C, Chatta G, Heath E, Quinn DI, Gandara DR. Twardowski P, et al. Among authors: lara pn. Urology. 2010 Oct;76(4):923-6. doi: 10.1016/j.urology.2010.04.025. Epub 2010 Jun 19. Urology. 2010. PMID: 20646741 Free PMC article. Clinical Trial.

2

High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer: targeted plasma levels are achievable clinically.

Lara PN Jr, Gandara DR, Wurz GT, Lau D, Uhrich M, Turrell C, Raschko J, Edelman MJ, Synold T, Doroshow J, Muggia F, Perez EA, DeGregorio M. Lara PN Jr, et al. Cancer Chemother Pharmacol. 1998;42(6):504-8. doi: 10.1007/s002800050852. Cancer Chemother Pharmacol. 1998. PMID: 9788578 Clinical Trial.

3

Gemcitabine/carboplatin combination regimens: importance of dose schedule.

Gandara DR, Lau DH, Lara PN Jr, Edelman MJ. Gandara DR, et al. Among authors: lara pn jr. Oncology (Williston Park). 2000 Jul;14(7 Suppl 4):26-30. Oncology (Williston Park). 2000. PMID: 10960942 Free article. Review.

4

Evolution of combined modality therapy for stage III non-small-cell lung cancer.

Gandara DR, Edelman M, Lara P, Roberts P, Leigh B. Gandara DR, et al. Oncology (Williston Park). 2000 Jul;14(7 Suppl 5):35-41. Oncology (Williston Park). 2000. PMID: 10981289 Review.

5

Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/paclitaxel consolidation for stage III non-small-cell lung cancer: a California Cancer Consortium phase II trial.

Lau D, Leigh B, Gandara D, Edelman M, Morgan R, Israel V, Lara P, Wilder R, Ryu J, Doroshow J. Lau D, et al. J Clin Oncol. 2001 Jan 15;19(2):442-7. doi: 10.1200/JCO.2001.19.2.442. J Clin Oncol. 2001. PMID: 11208837 Clinical Trial.

6

Gemcitabine in combination with new platinum compounds: an update.

Gandara DR, Edelman MJ, Lara PN, Lau DH. Gandara DR, et al. Among authors: lara pn. Oncology (Williston Park). 2001 Mar;15(3 Suppl 6):13-7. Oncology (Williston Park). 2001. PMID: 11301843 Free article. Review.

7

Neoadjuvant therapy for non-small cell lung cancer.

Gandara DR, Lara PN Jr, Goldberg Z, Roberts P, Lau DH. Gandara DR, et al. Among authors: lara pn jr. Anticancer Drugs. 2001 Feb;12 Suppl 1:S5-9. Anticancer Drugs. 2001. PMID: 11340902 Review.

8

Integration of new chemotherapeutic agents into chemoradiotherapy for stage III non--small cell lung cancer: focus on docetaxel.

Gandara DR, Lara PN Jr, Goldberg Z, Lau DH. Gandara DR, et al. Among authors: lara pn jr. Semin Oncol. 2001 Jun;28(3 Suppl 9):26-32. Semin Oncol. 2001. PMID: 11441412 Review.

9

Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: carboplatin and gemcitabine followed by paclitaxel.

Edelman MJ, Gandara DR, Lau DH, Lara P, Lauder IJ, Tracy D. Edelman MJ, et al. Cancer. 2001 Jul 1;92(1):146-52. doi: 10.1002/1097-0142(20010701)92:1<146::aid-cncr1302>3.0.co;2-n. Cancer. 2001. PMID: 11443620 Clinical Trial.

10

Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II California Cancer Consortium Trial.

Lara PN Jr, Gandara DR, Longmate J, Gumerlock PH, Lau DH, Edelman MJ, Gandour-Edwards R, Mack PC, Israel V, Raschko J, Frankel P, Perez EA, Lenz HJ, Doroshow JH. Lara PN Jr, et al. Cancer Chemother Pharmacol. 2001 Jul;48(1):22-8. doi: 10.1007/s002800100293. Cancer Chemother Pharmacol. 2001. PMID: 11488520 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

324 results

Search Page

Filters